Similar articles

• Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.

  Balzarini J, De Clercq E, Ayusawa D, Seno T. Balzarini J, et al. Methods Find Exp Clin Pharmacol. 1985 Jan;7(1):19-28. Methods Find Exp Clin Pharmacol. 1985. PMID: 3990443
• Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth.

  De Clercq E, Balzarini J, Torrence PF, Mertes MP, Schmidt CL, Shugar D, Barr PJ, Jones AS, Verhelst G, Walker RT. De Clercq E, et al. Mol Pharmacol. 1981 Mar;19(2):321-30. Mol Pharmacol. 1981. PMID: 7231392 No abstract available.
• Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.

  Roberts D, Franklin P, Odom G, Peck C, Chwang TL. Roberts D, et al. Mol Pharmacol. 1982 Nov;22(3):760-5. Mol Pharmacol. 1982. PMID: 6218391
• Pyrimidines and their nucleosides.

  Renis HE. Renis HE. Antibiot Chemother (1971). 1980;27:164-207. doi: 10.1159/000385393. Antibiot Chemother (1971). 1980. PMID: 6773471 Review. No abstract available.
• Antiviral and antitumor activities of 5-substituted 2'-deoxyuridines.

  De Clercq E. De Clercq E. Methods Find Exp Clin Pharmacol. 1980 Oct;2(5):253-67. Methods Find Exp Clin Pharmacol. 1980. PMID: 6765587 Review. No abstract available.